Abstract. The following methods were compared for their ability to detect latent pseudorabies virus in 24 pigs that had been experimentally infected with virulent pseudorabies virus: 1) in vivo reactivation by dexamethasone administration, 2) in vitro reactivation by 5 different techniques of explant culture or cocultivation of trigeminal ganglia, and 3) detection of pseudorabies virus genome in tissue digests of tonsils or trigeminal ganglia using the polymerase chain reaction. Reactivation of pseudorabies virus by administration of dexamethasone was attempted in 12 of 24 pigs in an effort to determine if this procedure would affect the detection of latent pseudorabies virus by any of the subsequent in vitro methods. Detection of latent virus by the polymerase chain reaction with trigeminal ganglia was the most successful method (24/24 were positive). The next most successful method was in vivo reactivation through the administration of dexamethasone (10/12 [83%] were positive). Only 1 in vitro reactivation technique, cocultivation involving digestion of the trigeminal ganglia with trypsin and collagenase and the addition of a hypomethylating agent to the medium, yielded positive results (5/24 [21%] were positive). The polymerase chain reaction performed on tissue digests of tonsils was much less effective (2/24 [8%] were positive) than it was with trigeminal ganglia. Reactivation by dexamethasone did not appear to have any effect on the subsequent detection of latency by any of the methods tested.
Pseudorabies (PR) is an economically important disease of swine caused by a herpesvirus (PR virus [PRV] ) of the subfamily Alphaherpesvirinae. Clinical manifestations of infection with virulent virus are most common in young pigs and are characterized primarily by respiratory and neurologic signs and often a high incidence of mortality. Older pigs may have few or no clinical signs, except for fetal deaths and abortions that sometimes follow infection of pregnant gilts and sows. 8 Pigs that survive acute infection with virulent PRV usually, if not always, become latently infected with the virus. 8 The trigeminal ganglia have been identified as one of the primary sites of latency; however, other cells, notably those of the tonsils, may also be affected 2, 6, 16, 22 Because of the potential for subsequent virus reactivation and shedding, latently infected virus carriers are believed to be the major interepizootic reservoir for the virus and the primary means by which the disease is perpetuated. The importance of virus carriers in the epizootiology of PR, especially in light of the recent implementation of PR eradication programs, has emphasized the need for a reliable test for identification of these carriers. Tests that have been described for this purpose include in vivo reactivation by administration of dexamethasone, 10, [11] [12] [13] 17, 18 in vitro reactivation by cocultivation or explant tissue techniques, 2, 5, 9, 13, [16] [17] [18] 22 in situ hybridization 5, 7 and the polymerase chain reaction (PCR). 1, 6, 13, 20 The success rate for detecting latent infection using these methods has varied markedly from study to study. Because only a single test was used in most of the studies, it is not clear whether these differences were due to the test under investigation or to other variables. However, in vivo reactivation of a latent infection may affect the results of in vitro tests done subsequently with tissues from the same pig. 13, 17 In the study reported here, the efficacy of several methods for detecting PRV latency in pigs previously exposed to virulent PRV was compared. The effect of vaccination and in vivo reactivation, alone or in combination, on subsequent in vitro detection of latency was also tested.
Materials and methods
Experimental design. A total of 24 pigs with various vaccination histories (6 groups of 4 pigs each) were selected for use in this study. All had been exposed oronasally to virulent PRV and thus were believed to be latently infected. Beginning at 10 weeks after exposure to virulent virus, 2 pigs of each group were treated for 5 consecutive days with dexamethasone. Nasal and throat swabs were collected from these pigs on days 0-11 and on day 14 after the beginning of dexa-methasone treatment to test for viral shedding. Six weeks after the beginning of the dexamethasone treatment, all of the pigs were euthanized. At necropsy, tonsils and trigeminal ganglia were collected and used for cocultivation, explant culture, and PCR. Sera from blood samples collected from all pigs just before the beginning of dexamethasone treatment and again just before euthanasia were titrated for PRV neutralizing antibody.
pigs. Prior to their use in this study, the 6 groups of pigs were treated as follows. 4 Pigs of groups 1-5 were vaccinated twice at a 4-wk interval with a vaccinia recombinant vaccine that contained PRV glycoprotein genes gII (group 1: pigs 1-4), gIII (group 2: pigs 5-8), or gp50 (group 3: pigs 9-12), with the vaccinia vector without inserted PRV genes (group 4: pigs 13-16), or with killed PRV vaccine (group 5: pigs 17-20) . Pigs of group 6 were sham-vaccinated age-matched controls (pigs 21-24). At 4 wk after the second vaccination, all pigs were exposed to 10 5 plaque forming units (PFU) of the Indiana-Funkhauser strain of PRV.
Dexamethasone treatment. Dexamethasone injections
were administered at about 12-hr intervals to 2 pigs from each group over a 5-day period in the following manner: 2.75 mg/kg intravenously and 0.55 mg/kg intramuscularly (IM) on the morning of the first day followed by 1.1 mg/kg IM on the evening of the first day and 1.1 mg/kg IM twice daily on days 2-5. The pigs were prophylactically given 22,000 U/kg of penicillin G IM daily during this 5-day period.
Virus neutralization. Virus neutralization (VN) tests against
PRV were run on sera taken 4 wk after challenge, 10 wk after challenge (prior to reactivation), and at necropsy by a microtiter method previously described.
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Virus isolation from nasal and throat swabs. Nasal and throat swabs collected during in vivo reactivation with dexamethasone were immediately submerged in 2 ml of transport medium (Eagle's minimal essential medium containing 75 U/ml penicillin, 75 µg/ml streptomycin, 75 µg/ml neomycin, 0.75 U/ml bacitracin, 200 µg/ml gentamycin, and 5 µg/ml amphotericin B) in sterile tubes and kept on ice until processed. Swab tubes were agitated and then centrifuged at 200 x g for 10 min. Two hundred microliters of supernatant were inoculated onto a bovine embryonic spleen (BESp) cell monolayer 14 in 1 well of a 24-well plate with 1 ml of inoculation medium (Eagle's minimal essential medium containing 25 U/ml penicillin, 25 µg/ml streptomycin, 25 µg/ml neomycin, 0.25 U/ml bacitracin, 500 µg/ml gentamycin, and 2 µg/ml amphotericin B). Plates were incubated at 37 C in a humidified atmosphere of 5% CO 2 and observed daily for cytopathic effect (CPE) for 1 wk.
Explant culture and cocultivation of trigeminal ganglia.
Explant culture or cocultivation of trigeminal ganglia was attempted using 5 different techniques. Halves of each trigeminal ganglion were pooled and minced into approximately 1 -mm 3 pieces. These pieces were then divided among the 5 techniques.
In technique 1, trigeminal pieces were placed into sterile test tubes with loose caps and 2 ml of inoculation medium containing 10% fetal bovine serum (FBS). 2, 9, 17 The tubes were incubated at 37 C in a humidified atmosphere of 5% CO 2 . The medium was changed weekly. Medium samples (1 ml) from the tubes were taken twice weekly for 6 wk and inoculated onto BESp cell monolayers on 24-well plates. The 24-well plates were kept under the same conditions as the tubes and were observed daily for CPE for 1 wk.
Technique 2 involved placing trigeminal pieces directly onto a BESp cell monolayer in a 24-well plate with 1 ml of inoculation medium containing 10% FBS. 2, 23 The plates were incubated as in technique 1. The wells were examined daily for CPE, and the fragments were transferred to a new well when the monolayer began to deteriorate. Samples were considered negative if there was no CPE after 3 serial passages (4-6 wk).
Technique 3 was exactly like technique 2 except that dexamethasone was added to the medium of different wells of the 24-well plate at concentrations of 0.1, 1.0, and 10 mg/ ml.
In technique 4, the trigeminal tissue was digested with 1 ml of a solution containing 0.1% collagenase and 0.25% trypsin in phosphate-buffered saline (PBS) at 37 C for 1 hr. 3, 5, 15, 21 The suspension was centrifuged at 200 x g, and the supernatant was discarded. Digested tissue was placed in 5 ml of inoculation medium containing 10% FBS and added to a BESp cell monolayer in a 25-cm 2 flask. The hypomethylating agent N-N-hexamethylene-bis-acetamide a was added to the medium to make a final concentration of 5 mM. The culture was incubated at 37 C in a humidified atmosphere of 5% CO 2 and monitored daily for CPE. The cells were passed at 2 wk. Cultures were kept 4 wk before they were considered negative.
In technique 5, the trigeminal pieces were coated with a few drops of chick embryo extract and placed in test tubes coated with avian plasma.
9,18 Tubes were placed in a roller drum and pieces were allowed to adhere for one hour at 37 C. Four milliliters of inoculation medium with 10% FBS was then added, and the tubes were again incubated at 37 C in the roller drum. Medium was changed twice weekly for 6 wk, and 1 ml of discarded medium was inoculated onto a BESp cell monolayer in a 24-well plate. The 24-well plate was incubated at 37 C in a humidified atmosphere of 5% CO 2 and examined daily for CPE for 1 wk.
Polymerase chain reaction. PCR was performed on digests of tonsil and on the other halves of the trigeminal ganglia. In addition, the pieces of trigeminal ganglion used in explant technique 1 above were frozen at -80 C after that procedure was finished, and PCR was performed on digests of these pieces. Fifty milligrams of tissue was brought to 5% weight per volume in digestion buffer containing 10 mM Tris (pH 9.0), 0.5% Tween-20, and proteinase K (250 µg/ml). After inactivation of proteinase K by boiling, 5-µ1 samples of the digestion mixture were used to run the PCR in 50-µ1 reaction mixture volumes. A nested set of primers was used to amplify a 334-bp segment followed by a 195-bp segment of the essential glycoprotein gII gene of PRV. Indirect fluorescent antibody test. Indirect fluorescent antibody (IFA) tests were used to confirm that virus isolated from cocultivation was PRV. Coverslips with monolayers of PK-15 cells, an established porcine kidney cell line, were infected with virus isolated from the cocultivations. After 17 hr, coverslips were fixed in a solution of 95% acetone and 5% ethanol for 10 min. One hundred microliters of PRV immune serum was added to the fixed coverslips, and they were placed into a humidity chamber at 37 C for 30 min then washed in PBS for 10 min. Coverslips were then flooded with 100 µ1 of fluorescein isothiocyanate-labeled goat antiswine IgG immunoglobulin digested with papain (prepared in our laboratory) and placed into the humidity chamber for 30 min. Coverslips were finally washed with PBS for 10 min and with distilled water for 5 min and mounted on glass slides with 1: 1 PBS-glycerol and observed for specific immunofluorescence.
Results
Virus was isolated from 10 of the 12 pigs treated with dexamethasone, resulting in a success rate of 83% ( Table 1 ). The 2 pigs that did not shed virus were from groups that had received PRV vaccines previously (pig 3, which received the gII recombinant, and pig 9, which received the gp50 recombinant). Nine of the 10 pigs from which virus was isolated began shedding by 48 hours after the first injection. The second day was also the day the greatest number of pigs shed virus. The duration and quantity of virus shed was variable, with pigs shedding for 1-8 days. Virus was isolated from more throat swabs than nasal swabs (36 and 25, respectively). For 3 pigs, virus was isolated from throat swabs only, and for 1 pig, virus was isolated from nasal swabs only (Table 1 ). There were no clinical signs of PR noted during or after dexamethasone administration.
Sera from all pigs had high PRV neutralization titers (range, 512-8,192 ) at the time of in vivo reactivation with dexamethasone. The sera from 2 pigs (nos. 4 and 14), which had received dexamethasone and shed PRV, had PRV VN titers 2-and 4-fold higher, respectively, at the time of necropsy than those of the samples taken just prior to dexamethasone administration (6 weeks apart). The sera from the 2 pigs that received dexamethasone but did not shed PRV (nos. 3 and 9) had 2-fold lower PRV VN titers over the same time period. Of the 8 other pigs that received dexamethasone and subsequently shed PRV, sera from 5 had the same titer detect PRV latency in swine Table 1 . Pseudorabies virus isolation* from pigs after dexamethasone treatment. and sera from 3 had 2-fold lower titers 6 weeks after dexamethasone administration. Of the 12 pigs that did not receive dexamethasone, sera from 5 had the same PRV VN titer and sera from 7 had 2-fold lower PRV VN titers 6 weeks after the other pigs had received dexamethasone (data not shown).
Only 1 cocultivation technique was successful in detecting latent virus. PRV, confirmed by IFA tests, was cocultivated from the trigeminal ganglia of 5 pigs (2 1%) using technique 4. CPE was detected in 3 of the cultures on the sixth day, in 1 culture on the seventh day, and in 1 culture on the eighth day after preparation. Four of the 5 pigs belonged to the experimental group that had received the nonrecombinant vaccinia virus previously. The other pig belonged to the control group. Of these 5 pigs, 3 were from the group that did not receive dexamethasone and 2 were from the group that did receive dexamethasone (Table 2) .
Initially, PRV was demonstrated by PCR in digests prepared from trigeminal ganglia in 23 of the 24 pigs (Table 2) . Digests were then prepared with pieces of trigeminal ganglia that had been used in the explant culture in technique 1. Latent virus was detected in 21 of the 24 pigs with this digest, including pig 3, which had been negative on the previous trial (Fig. 1) .
Two tonsilar digests were made, and PCR was run on each separately. Latent PRV was detected in 2/24 (8%) tonsils by PCR (Table 2) .
Discussion
All of the 24 pigs that had been exposed previously to virulent PRV were confirmed to be latently infected by 1 or more of the methods by which they were tested. The PCR with trigeminal ganglia and the in vivo reactivation by dexamethasone treatment were most reliable, detecting latency in 24 of 24 and 10 of 12 pigs, respectively. If, on the basis of these data and those of a previous study, 13 these 2 methods have similar sensitivity under a variety of different conditions, other considerations would probably dictate their selective use. The PCR can be completed more quickly than virus reactivation in vivo (1 day vs. at least several days), and if appropriate laboratory support were available, PCR would usually be the less expensive option. Conversely, reactivation in vivo would be the only choice when necropsy is contraindicated and when information regarding the reactivatability of a particular strain of PRV is needed.
The other methods used in this study for detecting latent infection with PRV, i.e., in vitro reactivation by cocultivation or explant culture of trigeminal ganglia and PCR with tonsil, were much. less reliable and appear to have little if any practical value if sensitivity is the primary consideration. The concentration of latent virus in tonsil is probably less than in the trigeminal ganglion, as demonstrated by hybridization studies using the two tissues. 5, 7 Thus, techniques that concentrate the virus, such as digestion of large tissue samples and extraction of the DNA, may explain the greater success in some studies that used PCR with tonsil.
6 However, the need for large samples negates the advantage of using a small tonsil biopsy as a method of detecting latency in live pigs. Only one in vitro reactivation technique in which the trigeminal ganglion was digested with trypsin and collagenase and a hypomethylating agent was added to the medium was successful. Which aspect of this technique resulted in its success versus the other techniques tried is unknown, but increased success reactivating herpes simplex virus in vitro using hypomethylating agents has been reported. 3, 15, 21 PRV was present in the trigeminal ganglion sections used for explant technique 1, as indicated by PCR performed on these tissues.
Several studies have shown a >2-fold increase in PRV VN antibody titer from 1 to 4 weeks after dexamethasone treatment in pigs that shed latent virus. 10, 11, [17] [18] [19] In this study, a rise in PRV VN antibody titer may have been more successful in detecting pigs that reactivated virus if serum samples had been obtained within a few weeks of reactivation or if radioimmunoprecipitation had been performed to determine if there was an increase in precipitating antibody activity.
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Virus reactivation in vivo had no apparent effect on the subsequent results of PCR or any of the in vivo reactivation techniques with trigeminal ganglia. Regardless of in vivo reactivation history, latent PRV was always detected by PCR and rarely detected by in vitro reactivation. These observations suggest that earlier failures to demonstrate latency by cocultivation or tissue explants of trigeminal ganglia of pigs that were believed 17 or known 3 to be latently infected with PRV is most likely explained by a lack of sensitivity of the procedures rather than by a refractory state or a depletion of latently infected cells caused by prior virus reactivation.
All pigs became latently infected regardless of their immune status at the time they were exposed to virulent virus, which is consistent with the results of earlier studies 13, 17 that included pigs immunized with conventional PRV vaccines rather than the mostly recombinant vaccines described here. Also consistent with the results of an earlier study 13 were 2 observations that suggested that although preexisting immunity does not preclude the establishment of latency with virulent virus, it might reduce its extent, or the likelihood of reactivation, or both. First, 2 of the 8 pigs that had humoral antibody at the time of challenge failed to shed virus after the beginning of dexamethasone treatment, whereas all of the 4 pigs that were free of antibody at the time of challenge did shed virus after the same treatment. Second, PRV was reactivated in vitro from the trigeminal ganglia of 0 of 16 and 5 of 8 pigs that did or did not, respectively, have humoral antibody for PRV at the time of challenge. Although the numbers are too few to draw a definitive conclusion, the collective implications of these and previous data 13 raise the possibility that immunity can directly or indirectly affect virus reactivation. The explanation may be no more than the probability that fewer cells are latently infected during acute infection of immune pigs and that only a fraction of these are involved in any single reactivation episode.
